What is a stock summary page? Click here for an overview.
Business Description
Pharma Aids Ltd
NAICS : 325412
ISIN : BD0462PHAID7
Description
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.97 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.36 | |||||
| Interest Coverage | 115.66 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 8.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.5 | |||||
| 3-Year EBITDA Growth Rate | 7.2 | |||||
| 3-Year EPS without NRI Growth Rate | 6.8 | |||||
| 3-Year FCF Growth Rate | 2.3 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.06 | |||||
| 9-Day RSI | 53.65 | |||||
| 14-Day RSI | 55.68 | |||||
| 3-1 Month Momentum % | -2.16 | |||||
| 6-1 Month Momentum % | -14.76 | |||||
| 12-1 Month Momentum % | -17.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 80.44 | |||||
| Days Sales Outstanding | 126.67 | |||||
| Days Payable | 4.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.45 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| 3-Year Dividend Growth Rate | -41.5 | |||||
| Forward Dividend Yield % | 0.45 | |||||
| 5-Year Yield-on-Cost % | 0.14 | |||||
| Shareholder Yield % | 0.35 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.57 | |||||
| Operating Margin % | 19.89 | |||||
| Net Margin % | 14.48 | |||||
| FCF Margin % | -2.25 | |||||
| ROE % | 17.73 | |||||
| ROA % | 12.63 | |||||
| ROIC % | 16.55 | |||||
| 3-Year ROIIC % | 13.65 | |||||
| ROC (Joel Greenblatt) % | 28.27 | |||||
| ROCE % | 24.68 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.7 | |||||
| PE Ratio without NRI | 27.87 | |||||
| Shiller PE Ratio | 38.56 | |||||
| Price-to-Owner-Earnings | 256.64 | |||||
| PS Ratio | 4.01 | |||||
| PB Ratio | 4.28 | |||||
| Price-to-Tangible-Book | 4.28 | |||||
| Price-to-Operating-Cash-Flow | 269.7 | |||||
| EV-to-EBIT | 19.88 | |||||
| EV-to-EBITDA | 18.46 | |||||
| EV-to-Revenue | 4.01 | |||||
| EV-to-FCF | -181.85 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Projected-FCF | 3.19 | |||||
| Price-to-Graham-Number | 2.3 | |||||
| Price-to-Net-Current-Asset-Value | 5.59 | |||||
| Earnings Yield (Greenblatt) % | 5.03 | |||||
| FCF Yield % | -0.56 | |||||
| Forward Rate of Return (Yacktman) % | -4.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma Aids Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 431.516 | ||
| EPS (TTM) (BDT) | 20.02 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.88 | ||
| 3-Year Sortino Ratio | -1.05 | ||
| Volatility % | 24.64 | ||
| 14-Day RSI | 55.68 | ||
| 14-Day ATR (BDT) | 13.200383 | ||
| 20-Day SMA (BDT) | 543.68 | ||
| 12-1 Month Momentum % | -17.31 | ||
| 52-Week Range (BDT) | 515 - 819.8 | ||
| Shares Outstanding (Mil) | 3.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharma Aids Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharma Aids Ltd Stock Events
| Event | Date | Price (BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharma Aids Ltd Frequently Asked Questions
What is Pharma Aids Ltd(DHA:PHARMAID)'s stock price today?
The current price of DHA:PHARMAID is BDT554.50. The 52 week high of DHA:PHARMAID is BDT819.80 and 52 week low is BDT515.00.
When is next earnings date of Pharma Aids Ltd(DHA:PHARMAID)?
The next earnings date of Pharma Aids Ltd(DHA:PHARMAID) is .
Does Pharma Aids Ltd(DHA:PHARMAID) pay dividends? If so, how much?
The Dividend Yield %  of Pharma Aids Ltd(DHA:PHARMAID) is 0.45% (As of Today), Highest Dividend Payout Ratio of Pharma Aids Ltd(DHA:PHARMAID) was 0.44. The lowest was 0.05. And the median was 0.31. The  Forward Dividend Yield % of Pharma Aids Ltd(DHA:PHARMAID) is 0.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers